MWA
TECH icon

Medallion Wealth Advisors’s Bio-Techne TECH Stock Holding History

Medallion Wealth Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.1K Buy
1,205
+5
+0.4% +$270 0.03% 370
2026
Q1 		$62.7K Hold
1,200
– – 0.02% 431
2025
Q4 		$70.6K Hold
1,200
– – 0.02% 414
2025
Q3 		$66.8K Hold
1,200
– – 0.02% 421
2025
Q2 		$62.5K Hold
1,200
– – 0.02% 422
2025
Q1 		$68.8K Sell
1,200
-397
-25% -$26.9K 0.03% 369
2024
Q4 		$115K Buy
+1,597
New +$117K 0.06% 269

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Medallion Wealth Advisors's TECH Position: Q2 2026 in Review

Medallion Wealth Advisors increased its Bio-Techne (TECH) stake by 0.42% in Q2 2026, buying an estimated $270 and bringing the position to 1,205 shares worth $85.1K. The position accounts for 0.03% of the portfolio, ranked #370.

Medallion Wealth Advisors first reported a position in TECH in Q4 2024 and has held it in 7 quarters since. The position peaked at $115K in Q4 2024. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Medallion Wealth Advisors held 1,205 shares of Bio-Techne worth $85.1K as of Q2 2026.
  • Medallion Wealth Advisors bought 5 Bio-Techne shares in Q2 2026, an estimated $270.
  • Bio-Techne made up 0.03% of Medallion Wealth Advisors's portfolio in Q2 2026, its #370 holding.
  • Medallion Wealth Advisors first reported a position in Bio-Techne in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Bio-Techne position peaked at $115K in Q4 2024.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.